Granite Point Capital Management’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-176,456
| Closed | -$295K | – | 103 |
|
|
2022
Q3 | $295K | Sell |
176,456
-1
| -0% | -$2 | 0.12% | 68 |
|
|
2022
Q2 | $489K | Hold |
176,457
| – | – | 0.12% | 64 |
|
|
2022
Q1 | $590K | Buy |
176,457
+120,000
| +213% | +$401K | 0.12% | 78 |
|
|
2021
Q4 | $347K | Buy |
56,457
+9,668
| +21% | +$59.4K | 0.06% | 92 |
|
|
2021
Q3 | $649K | Buy |
+46,789
| New | +$649K | 0.05% | 91 |
|
|
2021
Q1 | – | Sell |
-128,440
| Closed | -$3.72M | – | 176 |
|
|
2020
Q4 | $3.72M | Sell |
128,440
-18,227
| -12% | -$528K | 0.19% | 24 |
|
|
2020
Q3 | $5.52M | Hold |
146,667
| – | – | 0.3% | 13 |
|
|
2020
Q2 | $4.88M | Buy |
+146,667
| New | +$4.88M | 0.25% | 16 |
|